Lyrica Receives CHMP Opinion For The Treatment Of Generalized Anxiety Disorder In Adults

... Pfizer Inc said today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending marketing authorization of Lyrica® (pregabalin), a novel mechanism for the treatment of generalized anxiety disorder (GAD) in adults. The CHMP''s positive recommendation will be reviewed by the European Commission, which has authority to approve medicines for the European Union... click link for more info. ...